drugset / Trial / NCT01052259
Efficacy and Safety of Deoxyspergualin in Renal Transplant Patient With Chronic Rejection
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study to examine the efficacy and safety of cycling treatment of deoxyspergualin in renal transplant patients with biopsy-proven chronic rejection.
Timeline
- Start
- 2009-06
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deoxyspergualin | Unknown | 3 mg/kg | Intravenous |
| Subject | Deoxyspergualin | Unknown | 5 mg/kg | Intravenous |